Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of AbCellera Biologics Inc (NASDAQ: ABCL) was $2.20 for the day, down -5.58% from the previous closing price of $2.33. In other words, the price has decreased by -$5.58 from its previous closing price. On the day, 5.61 million shares were traded.
Ratios:
Our analysis of ABCL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.81 and its Current Ratio is at 9.81. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 22, 2024, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $9.
On December 05, 2023, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $6.KeyBanc Capital Markets initiated its Overweight rating on December 05, 2023, with a $6 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 22.74 while its Price-to-Book (P/B) ratio in mrq is 0.62.
Stock Price History:
Over the past 52 weeks, ABCL has reached a high of $5.12, while it has fallen to a 52-week low of $2.20. The 50-Day Moving Average of the stock is -27.03%, while the 200-Day Moving Average is calculated to be -24.78%.
Shares Statistics:
A total of 295.76M shares are outstanding, with a floating share count of 223.90M. Insiders hold about 24.86% of the company’s shares, while institutions hold 37.06% stake in the company.
